Takeda executive proposes $1.12M share sale

The notice says a sale during the prior three months was conducted to satisfy tax obligations tied to vesting effective July 13, 2026.

Available on EDGAR 10/30/2026 - 06:40 PM EDT Accepted by SEC EDGAR 10/30/2026 - 06:40 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Takeda Pharmaceutical Co Ltd (TAK) is named as issuer in a notice reporting that Giles Richard Platford, President, International Business Unit, proposes to sell 55,617 American Depositary Shares (ADSs), with an aggregate market value of $1,121,794.89. Interactive Brokers LLC is listed as broker, NYSE as the exchange, and November 1, 2026, as the approximate sale date. The notice also lists 31,083 ADSs sold on August 10, 2026, for $531,519.30. Its remarks state that the sale during the past three months was conducted to satisfy tax obligations connected with share vesting effective July 13, 2026.

Key Figures

ADSs proposed for sale: 55,617 ADSs Aggregate market value: $1,121,794.89 Approximate sale date: Approximately November 1, 2026 +3 more

6 metrics

ADSs proposed for sale 55,617 ADSs Proposed sale by Giles Richard Platford

Aggregate market value $1,121,794.89 Proposed sale

Approximate sale date Approximately November 1, 2026 Proposed sale

ADSs sold 31,083 ADSs Sale reported during the past three months; August 10, 2026

Aggregate market value $531,519.30 Sale reported during the past three months

Share vesting effective date July 13, 2026 Vesting connected with the tax obligations described for the past-three-month sale

Key Terms

American Depositary Shares (ADSs), Restricted Stock Unit Awards - Vested, Rule 144

3 terms

American Depositary Shares (ADSs) financial

"American Depositary Shares (ADSs)"

A U.S.-listed certificate that stands for a specific number of shares in a non‑U.S. company held by a U.S. bank, making the foreign stock tradable on American exchanges in dollars. Think of it like a local voucher that represents ownership of an overseas product — it lets U.S. investors buy and sell foreign companies without handling foreign currency or foreign brokerage accounts, but it can affect dividends, voting rights, fees, liquidity and exposure to currency and regulatory differences.

Restricted Stock Unit Awards - Vested financial

"Restricted Stock Unit Awards - Vested"

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TAK ADSs does Giles Richard Platford propose to sell?

Giles Richard Platford, President, International Business Unit, reported a proposed sale of 55,617 ADSs, with an aggregate market value of $1,121,794.89 and an approximate sale date of November 1, 2026. Interactive Brokers LLC is listed as broker, and NYSE as the exchange.

What were Giles Richard Platford's recent TAK ADS sales?

The reported sale during the past three months was 31,083 ADSs on August 10, 2026, with an aggregate market value of $531,519.30. The remarks state that the sale was conducted to satisfy tax obligations connected with share vesting effective July 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001977620
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TAKEDA PHARMACEUTICAL CO LTD
SEC File Number	001-38757
Address of Issuer	1-1, Nihonbashi-Honcho 2-chome Chuo-ku, Tokyo JAPAN 103-8668
Phone	81-3-3278-2111
Name of Person for Whose Account the Securities are To Be Sold	Platford Giles Richard
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	President, International Business Unit

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich, CT 06830	55617	1121794.89	198318946	11/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/30/2024	Restricted Stock Unit Awards - Vested	Takeda Pharmaceutical Company Limited			55617	07/30/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Giles Richard Platford 650 E KENDALL STREET CAMBRIDGE, MA 02142	ADSs	08/10/2026	31083	531519.30

144: Remarks and Signature

Remarks	Sale during the past 3 months was conducted in order to satisfy tax obligations in connection with share vesting effective July 13, 2026.
Date of Notice	10/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kate Huleatt, by power of attorney for Giles R. Platford
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)